Clinical Trials on Hypotrichosis

Total 520 results

Follicum AB

Completed

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

Alopecia | Hirsutism | Hypertrichosis

Germany
Tel-Aviv Sourasky Medical Center

Unknown

Efficacy of Topical Gentamycin for Hereditary Hypotrichosis Simplex Caused by Nonsense Mutations in CDSN

Hereditary Hypotrichosis Simplex
Northwestern University

Recruiting

Platelet-rich Plasma for Eyebrows

Eyebrow Hypotrichosis

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Eyelash Hypotrichosis

Korea, Republic of
Allergan

Completed

Bimatoprost in the Treatment of Eyelash Hypotrichosis

Idiopathic Eyelash Hypotrichosis

Russian Federation, Sweden, United States, United Kingdom
Allergan

Completed

Bimatoprost for the Treatment of Eyebrow Hypotrichosis

Eyebrow Hypotrichosis

United States, Canada
Allergan

Completed

An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

Eyelash Hypotrichosis

United States
Allergan

Completed

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

Eyelash Hypotrichosis

United States
Mae Fah Luang University Hospital

Completed

Minoxidil 2% for Eyebrow Enhancement

Hypotrichosis of Eyebrows | Thinning Eyebrows

Thailand
Mae Fah Luang University Hospital

Completed

Minoxidil 1% for Eyebrow Enhancement

Eyebrow Hypotrichosis | Thin Eyebrow

Thailand
Allergan

Completed

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

Alopecia Areata | Eyelash Hypotrichosis

United States, Brazil
Aneira Pharma, Inc.

Recruiting

Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

Hypotrichosis

United States
ATS Clinical Research
Allergan

Completed

Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows

Hypotrichosis

United States
Allergan

Completed

Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

Hypotrichosis

United States
Kenneth Beer
Allergan

Completed

Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Hypotrichosis

United States
Duke University

Completed

Study of Bimatoprost Gel on Eyelash Growth

Hypotrichosis | Madarosis

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin

Hypotrichosis

United States, United Kingdom
Allergan

Completed

Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

Hypotrichosis

United States
Alexander Shayesteh

Recruiting

Treatment of Hypertrichosis With Intense Pulsed Light

Hypertrichosis | Hirsutism - Hypertrichosis

Sweden
Michael Milano, MD,PhD

Terminated

Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy

Alopecia

United States
The New York Eye & Ear Infirmary

Completed

Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)

Alopecia

United States
University of California, Irvine
Beckman Laser Institute

Active, not recruiting

Fractional Photothermolysis for Hair Follicle Induction

Alopecia

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

Alopecia

Korea, Republic of
Lumenis Be Ltd.

Active, not recruiting

Fractional Non-ablative Laser for the Treatment of Hair Loss

Alopecia

Ukraine
Histogen

Unknown

Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss

Alopecia

United States
GlaxoSmithKline

Completed

Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers

Alopecia

Australia
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

Alopecia | Baldness

United States, Germany
Biolab Sanus Farmaceutica

Not yet recruiting

BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

Telogen Effluvium
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women

Telogen Effluvium

France
Derming SRL

Completed

Efficacy Evaluation of the Activity of a Cosmetic Product (Topical Use) on Hair Regrowth vs Placebo

Hypertrichosis

Italy
Sanofi

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

Alopecia Areata
Assiut University

Not yet recruiting

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Zagazig University

Recruiting

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

Alopecia Areata

Egypt
NEXTGEN Bioscience

Not yet recruiting

Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata

Alopecia Areata
Al-Azhar University

Not yet recruiting

Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata

Alopecia Areata

Egypt
AbbVie

Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia Areata

United States, Australia, Japan, Puerto Rico, New Zealand, China, Canada, Brazil, United Kingdom, Korea, Republic of, Chile
Sohag University

Recruiting

Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata

Alopecia Areata

Egypt
Sohag University

Not yet recruiting

Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Montefiore Medical Center
Paxman

Recruiting

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

Alopecia

United States
Institute of Biophysics and Cell Engineering of...
Belarusian State Medical University

Not yet recruiting

Treatment of Alopecia Using Follicular Stem Cells

Alopecia
Al-Azhar University

Recruiting

Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata (AA)

Alopecia Areata

Egypt
Tel-Aviv Sourasky Medical Center

Not yet recruiting

Fecal Transplant for Alopecia Areata

Alopecia Areata
Alexandria University

Not yet recruiting

Intralesional Vitamin D in Alopecia Areata

Alopecia Areata

Egypt
Suzhou Koshine Biomedica, Inc.

Completed

To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia

Alopecia

China
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)

Alopecia Areata

Israel, China, United States, Puerto Rico, Korea, Republic of, Taiwan, Australia, Japan, Brazil, Argentina
Dr. Peter C. Friedman

Completed

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Androgenetic Alopecia

United States
CorEvitas

Enrolling by invitation

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Alopecia Areata

United States

3

Subscribe